The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 20, 2021
Merck and Eisai announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted positive ...
read more
Wednesday, October 20, 2021
Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of VAXNEUVANCE...
read more
Wednesday, October 20, 2021
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more
Wednesday, October 20, 2021
Boehringer Ingelheim announced the FDA approved the supplemental Biologics License Application (sBLA) for Cyltezo® (adalimumab-adbm) as the first ...
read more
Wednesday, October 20, 2021
Ionis Pharmaceuticals, Inc. partner Biogen announced topline results from its placebo-controlled pivotal Phase 3 VALOR study of tofersen (BIIB067), an...
read more
Thursday, October 21, 2021
The expanded age indication is supported by a Phase 3 clinical study demonstrating that FLUCELVAX QUADRIVALENT was as safe and immunogenic as a ...
read more
Thursday, October 21, 2021
UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were ...
read more
Wednesday, October 27, 2021
Alkermes plc announced that the FDA has granted Fast Track designation to nemvaleukin alfa (nemvaleukin), the company's novel, investigational, ...
read more
Thursday, October 28, 2021
Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that ...
read more
Wednesday, October 27, 2021
Merck announced positive top-line results from two pivotal Phase 3 trials of the investigational, once-daily oral fixed dose combination pill of ...
read more
Tuesday, October 26, 2021
Merck announced that the European Commission (EC) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy for the first-...
read more
Thursday, October 28, 2021
Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with ...
read more
Wednesday, November 03, 2021
Stingthera, Inc. announced it has entered into a clinical trial collaboration agreement with Merck to evaluate the combination of SNX281, Stingthera’s...
read more
Wednesday, November 03, 2021
AbCellera announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for ...
read more
Wednesday, November 03, 2021
ANI Pharmaceuticals announced the FDA approval of the company’s supplemental New Drug Application (sNDA) for Purified Cortrophin™ Gel (Repository ...
read more